批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2022/12/07 |
ORIG-1(原始申请) |
Approval |
|
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:BENDAMUSTINE HYDROCHLORIDE 剂型/给药途径:POWDER;INTRAVENOUS 规格:25MG/VIAL 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022249 |
002 |
NDA |
TREANDA |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
25MG/VIAL |
Prescription |
Yes |
Yes |
AP |
2009/05/01
|
CEPHALON |
205376 |
001 |
ANDA |
BENDAMUSTINE HYDROCHLORIDE |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
25MG/VIAL |
Prescription |
No |
No |
AP |
2022/12/07
|
DR REDDYS |
205574 |
001 |
ANDA |
BENDAMUSTINE HYDROCHLORIDE |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
25MG/VIAL |
Prescription |
No |
No |
AP |
2022/12/07
|
ACCORD HLTHCARE |
205447 |
001 |
ANDA |
BENDAMUSTINE HYDROCHLORIDE |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
25MG/VIAL |
Discontinued |
No |
No |
AP |
2023/02/14
|
BRECKENRIDGE |
204104 |
001 |
ANDA |
BENDAMUSTINE HYDROCHLORIDE |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
25MG/VIAL |
Discontinued |
No |
No |
AP |
2023/04/28
|
NORVIUM BIOSCIENCE |
204230 |
001 |
ANDA |
BENDAMUSTINE HYDROCHLORIDE |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
25MG/VIAL |
Prescription |
No |
No |
AP |
2023/06/05
|
APOTEX |
211001 |
001 |
ANDA |
BENDAMUSTINE HYDROCHLORIDE |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
25MG/VIAL |
Prescription |
No |
No |
AP |
2023/06/05
|
MEITHEAL |
214739 |
001 |
ANDA |
BENDAMUSTINE HYDROCHLORIDE |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
25MG/VIAL |
Prescription |
No |
No |
AP |
2023/06/05
|
EUGIA PHARMA |
活性成分:BENDAMUSTINE HYDROCHLORIDE 剂型/给药途径:POWDER;INTRAVENOUS 规格:100MG/VIAL 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022249 |
001 |
NDA |
TREANDA |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
100MG/VIAL |
Prescription |
Yes |
Yes |
AP |
2008/03/20
|
CEPHALON |
205376 |
002 |
ANDA |
BENDAMUSTINE HYDROCHLORIDE |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
100MG/VIAL |
Prescription |
No |
No |
AP |
2022/12/07
|
DR REDDYS |
205574 |
002 |
ANDA |
BENDAMUSTINE HYDROCHLORIDE |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
100MG/VIAL |
Prescription |
No |
No |
AP |
2022/12/07
|
ACCORD HLTHCARE |
205447 |
002 |
ANDA |
BENDAMUSTINE HYDROCHLORIDE |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
100MG/VIAL |
Discontinued |
No |
No |
AP |
2023/02/14
|
BRECKENRIDGE |
204104 |
002 |
ANDA |
BENDAMUSTINE HYDROCHLORIDE |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
100MG/VIAL |
Discontinued |
No |
No |
AP |
2023/04/28
|
NORVIUM BIOSCIENCE |
204230 |
002 |
ANDA |
BENDAMUSTINE HYDROCHLORIDE |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
100MG/VIAL |
Prescription |
No |
No |
AP |
2023/06/05
|
APOTEX |
211001 |
002 |
ANDA |
BENDAMUSTINE HYDROCHLORIDE |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
100MG/VIAL |
Prescription |
No |
No |
AP |
2023/06/05
|
MEITHEAL |
214739 |
002 |
ANDA |
BENDAMUSTINE HYDROCHLORIDE |
BENDAMUSTINE HYDROCHLORIDE |
POWDER;INTRAVENOUS |
100MG/VIAL |
Prescription |
No |
No |
AP |
2023/06/05
|
EUGIA PHARMA |